ProteoNic specialises in enhancing protein expression by optimising the messenger RNA (mRBA) instead of DNA transcription methods. Chr Hansen is licensing its construct design and cloning methods, and will be receiving hands-on support from its new partner.

Hans van den Brink, department manager enzymes at Chr Hansen, said: “ProteoNic’s technology will be an important part of our strategy that is aimed at maintaining and improving our competitiveness in the area of production of dairy enzymes.”